Kala Pharmaceuticals, Inc. (KALA)

USD 3.75

(-11.56%)

Total Assets Summary of Kala Pharmaceuticals, Inc.

  • Kala Pharmaceuticals, Inc.'s latest annual total assets in 2023 was 55.94 Million USD , down -35.56% from previous year.
  • Kala Pharmaceuticals, Inc.'s latest quarterly total assets in 2024 Q2 was 61.6 Million USD , up 16.17% from previous quarter.
  • Kala Pharmaceuticals, Inc. reported annual total assets of 86.82 Million USD in 2022, down -37.73% from previous year.
  • Kala Pharmaceuticals, Inc. reported annual total assets of 139.42 Million USD in 2021, down -37.08% from previous year.
  • Kala Pharmaceuticals, Inc. reported quarterly total assets of 53.03 Million USD for 2024 Q1, down -5.21% from previous quarter.
  • Kala Pharmaceuticals, Inc. reported quarterly total assets of 66.5 Million USD for 2023 Q2, down -7.93% from previous quarter.

Annual Total Assets Chart of Kala Pharmaceuticals, Inc. (2023 - 2015)

Historical Annual Total Assets of Kala Pharmaceuticals, Inc. (2023 - 2015)

Year Total Assets Total Assets Growth
2023 55.94 Million USD -35.56%
2022 86.82 Million USD -37.73%
2021 139.42 Million USD -37.08%
2020 221.6 Million USD 43.6%
2019 154.32 Million USD -30.16%
2018 220.96 Million USD 90.27%
2017 116.13 Million USD 150.67%
2016 46.32 Million USD 448.4%
2015 8.44 Million USD 0.0%

Peer Total Assets Comparison of Kala Pharmaceuticals, Inc.

Name Total Assets Total Assets Difference
Cosmos Health Inc. 66.29 Million USD 15.607%
Safety Shot Inc 12.7 Million USD -340.225%
Bright Green Corporation 17.4 Million USD -221.49%
Embecta Corp. 1.21 Billion USD 95.393%
ANI Pharmaceuticals, Inc. 904.42 Million USD 93.814%
Aquestive Therapeutics, Inc. 57.41 Million USD 2.558%
Collegium Pharmaceutical, Inc. 1.14 Billion USD 95.106%
Dynavax Technologies Corporation 997.09 Million USD 94.389%
Esperion Therapeutics, Inc. 205.79 Million USD 72.813%
Intra-Cellular Therapies, Inc. 728.29 Million USD 92.318%
Pacira BioSciences, Inc. 1.57 Billion USD 96.446%
PainReform Ltd. 9.93 Million USD -463.434%
Sunshine Biopharma, Inc. 27.34 Million USD -104.589%
Sunshine Biopharma, Inc. 27.34 Million USD -104.589%
SCYNEXIS, Inc. 128.41 Million USD 56.43%
China SXT Pharmaceuticals, Inc. 23.12 Million USD -141.92%
Journey Medical Corporation 76.84 Million USD 27.196%
Alpha Teknova, Inc. 128.58 Million USD 56.489%
Procaps Group, S.A. 460.18 Million USD 87.842%
Theratechnologies Inc. 77.76 Million USD 28.057%
Harrow Health, Inc. 311.75 Million USD 82.054%
Sonoma Pharmaceuticals, Inc. 14.89 Million USD -275.673%
Biofrontera Inc. 27.93 Million USD -100.304%
DURECT Corporation 45.18 Million USD -23.811%
Supernus Pharmaceuticals, Inc. 1.4 Billion USD 96.029%
Cronos Group Inc. 1.13 Billion USD 95.067%
OptiNose, Inc. 107.72 Million USD 48.065%
Ironwood Pharmaceuticals, Inc. 471.07 Million USD 88.123%
RedHill Biopharma Ltd. 23.04 Million USD -142.759%
Organogenesis Holdings Inc. 460.02 Million USD 87.838%
Guardion Health Sciences, Inc. 11.91 Million USD -369.443%
Cumberland Pharmaceuticals Inc. 81.77 Million USD 31.583%
Radius Health, Inc. 1.71 Billion USD 96.739%
Universe Pharmaceuticals INC 53.28 Million USD -4.996%
ProPhase Labs, Inc. 91.92 Million USD 39.138%
Phibro Animal Health Corporation 982.18 Million USD 94.304%
Procaps Group S.A. 460.18 Million USD 87.842%
Alvotech 950.09 Million USD 94.111%
TherapeuticsMD, Inc. 43.3 Million USD -29.186%
Viatris Inc. 47.68 Billion USD 99.883%
Rockwell Medical, Inc. 52.17 Million USD -7.237%
Aytu BioPharma, Inc. 118.09 Million USD 52.624%
SIGA Technologies, Inc. 254.83 Million USD 78.045%
Tilray Brands, Inc. 4.33 Billion USD 98.709%
Lifecore Biomedical, Inc. 273.7 Million USD 79.558%
Shineco, Inc. 84.17 Million USD 33.536%
PetIQ, Inc. 868.22 Million USD 93.556%
Regencell Bioscience Holdings Limited 8.43 Million USD -563.043%
Incannex Healthcare Limited 17.04 Million USD -228.204%
Neurocrine Biosciences, Inc. 3.25 Billion USD 98.279%
Alimera Sciences, Inc. 153.52 Million USD 63.557%
Silver Spike Investment Corp. 88.57 Million USD 36.835%
Assertio Holdings, Inc. 286.41 Million USD 80.466%
Shuttle Pharmaceuticals Holdings, Inc. 5.95 Million USD -840.045%
Petros Pharmaceuticals, Inc. 33.79 Million USD -65.55%
Clever Leaves Holdings Inc. 31.24 Million USD -79.077%
Cyclo Therapeutics, Inc. 13.24 Million USD -322.335%
Avadel Pharmaceuticals plc 261.12 Million USD 78.574%
Hempacco Co., Inc. 18.04 Million USD -210.086%
Talphera, Inc. 20.39 Million USD -174.327%
Alvotech 950.09 Million USD 94.111%
Eagle Pharmaceuticals, Inc. 406.16 Million USD 86.225%
Lantheus Holdings, Inc. 1.65 Billion USD 96.612%
Currenc Group, Inc. 141.49 Million USD 60.457%
Kamada Ltd. 351.96 Million USD 84.104%
Indivior PLC 1.95 Billion USD 97.133%
Evoke Pharma, Inc. 7.06 Million USD -691.521%
Flora Growth Corp. 23.62 Million USD -136.811%
Cyclo Therapeutics, Inc. 13.24 Million USD -322.335%
Evolus, Inc. 188.99 Million USD 70.397%
HUTCHMED (China) Limited 1.27 Billion USD 95.628%
Amphastar Pharmaceuticals, Inc. 1.51 Billion USD 96.302%
Akanda Corp. 8.83 Million USD -532.908%